Antibacterial activity of the structurally novel C-2 amine-substituted analogues based on quinoxaline.

IF 4.1 4区 医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Yuting Liu, Pengju Yang, Yunyun Zhou, Zhiwen Zhou
{"title":"Antibacterial activity of the structurally novel C-2 amine-substituted analogues based on quinoxaline.","authors":"Yuting Liu, Pengju Yang, Yunyun Zhou, Zhiwen Zhou","doi":"10.1039/d4md00670d","DOIUrl":null,"url":null,"abstract":"<p><p>In the current study, we have designed and prepared a series of quinoxaline-based compounds, which were derived from <i>o</i>-phenylenediamine. Among them, compounds 5m-5p displayed good to moderate antibacterial activity with MICs of 4-16 μg mL<sup>-1</sup> against <i>S. aureus</i>, 8-32 μg mL<sup>-1</sup> against <i>B. subtilis</i>, 8-32 μg mL<sup>-1</sup> against MRSA and 4-32 μg mL<sup>-1</sup> against <i>E. coli</i>, respectively. Compound 5p, identified as a potent broad-spectrum antibacterial agent, demonstrated the strongest inhibitory effects against a range of bacterial strains and low cytotoxicity, thereby warranting further investigation. Compound 5p not only demonstrated the ability to disperse established bacterial biofilms but also induced a slower development of bacterial resistance compared to norfloxacin. Moreover, bactericidal time-kill kinetic studies revealed that at a high concentration of 3MIC, compound 5p was capable of directly killing MRSA cells. The subsequent postcontact effect (PCE) results showed that the growth rate of viable bacteria (MRSA) was greatly impacted and did not recover in less than 24 hours, even after antibacterial agent 5p was removed. The drug-like properties and ADME prediction exhibited that 5m-5p obeyed Lipinski's rule of five and therefore presumably maintained moderate to good bioavailability and human intestinal absorption rate when administered orally. Mechanistic investigations have elucidated that compound 5p exerted its antibacterial effect by compromising the structural integrity of bacterial cell membranes, resulting in the leakage of intracellular constituents and ultimately causing bacterial demise. Further studies <i>in vivo</i> have demonstrated that 5p exhibited potent antibacterial efficacy against MRSA in murine corneal infection models, particularly at elevated concentrations. The current dataset has also been meticulously analyzed to delineate the structure-activity relationships (SARs) of the synthesized compounds.</p>","PeriodicalId":21462,"journal":{"name":"RSC medicinal chemistry","volume":" ","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577936/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RSC medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1039/d4md00670d","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In the current study, we have designed and prepared a series of quinoxaline-based compounds, which were derived from o-phenylenediamine. Among them, compounds 5m-5p displayed good to moderate antibacterial activity with MICs of 4-16 μg mL-1 against S. aureus, 8-32 μg mL-1 against B. subtilis, 8-32 μg mL-1 against MRSA and 4-32 μg mL-1 against E. coli, respectively. Compound 5p, identified as a potent broad-spectrum antibacterial agent, demonstrated the strongest inhibitory effects against a range of bacterial strains and low cytotoxicity, thereby warranting further investigation. Compound 5p not only demonstrated the ability to disperse established bacterial biofilms but also induced a slower development of bacterial resistance compared to norfloxacin. Moreover, bactericidal time-kill kinetic studies revealed that at a high concentration of 3MIC, compound 5p was capable of directly killing MRSA cells. The subsequent postcontact effect (PCE) results showed that the growth rate of viable bacteria (MRSA) was greatly impacted and did not recover in less than 24 hours, even after antibacterial agent 5p was removed. The drug-like properties and ADME prediction exhibited that 5m-5p obeyed Lipinski's rule of five and therefore presumably maintained moderate to good bioavailability and human intestinal absorption rate when administered orally. Mechanistic investigations have elucidated that compound 5p exerted its antibacterial effect by compromising the structural integrity of bacterial cell membranes, resulting in the leakage of intracellular constituents and ultimately causing bacterial demise. Further studies in vivo have demonstrated that 5p exhibited potent antibacterial efficacy against MRSA in murine corneal infection models, particularly at elevated concentrations. The current dataset has also been meticulously analyzed to delineate the structure-activity relationships (SARs) of the synthesized compounds.

基于喹喔啉的结构新颖的 C-2 氨基取代类似物的抗菌活性。
在本研究中,我们设计并制备了一系列基于喹喔啉的化合物,这些化合物由邻苯二胺衍生而来。其中,化合物 5m-5p 显示出良好至中等的抗菌活性,对金黄色葡萄球菌的 MIC 值分别为 4-16 μg mL-1、对枯草杆菌的 8-32 μg mL-1、对 MRSA 的 8-32 μg mL-1 和对大肠杆菌的 4-32 μg mL-1。化合物 5p 被鉴定为一种强效广谱抗菌剂,对一系列细菌菌株具有最强的抑制作用,且细胞毒性低,因此值得进一步研究。与诺氟沙星相比,化合物 5p 不仅能驱散已形成的细菌生物膜,还能减缓细菌耐药性的产生。此外,杀菌时间动力学研究表明,在 3MIC 的高浓度下,化合物 5p 能够直接杀死 MRSA 细胞。随后的接触后效应(PCE)结果表明,即使去除抗菌剂 5p 后,存活细菌(MRSA)的生长率也会受到极大影响,且在 24 小时内不会恢复。类药物特性和 ADME 预测表明,5m-5p 遵循利宾斯基的五则运算法则,因此在口服给药时可能保持中等至良好的生物利用度和人体肠道吸收率。机理研究阐明,化合物 5p 通过破坏细菌细胞膜结构的完整性,导致细胞内成分泄漏,最终导致细菌死亡,从而发挥抗菌作用。进一步的体内研究表明,在小鼠角膜感染模型中,5p 对 MRSA 具有很强的抗菌效果,尤其是在浓度升高的情况下。我们还对当前的数据集进行了细致分析,以确定合成化合物的结构-活性关系(SARs)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
2.40%
发文量
129
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信